Literature DB >> 32345591

RECOVERY trial: the UK covid-19 study resetting expectations for clinical trials.

Emma Wilkinson1.   

Abstract

Entities:  

Year:  2020        PMID： 32345591     DOI： 10.1136/bmj.m1626

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  25 in total

Review 1.  SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression.

Authors:  Jairo Cajamarca-Baron; Diana Guavita-Navarro; Jhon Buitrago-Bohorquez; Laura Gallego-Cardona; Angela Navas; Hector Cubides; Ana María Arredondo; Alejandro Escobar; Adriana Rojas-Villarraga
Journal:  Reumatol Clin (Engl Ed)       Date:  2020-09-11

2.  Pandemic preparedness and responsiveness of research review committees: lessons from review of COVID-19 protocols at KEMRI Wellcome Trust Research Programme in Kenya.

Authors:  Alex Hinga; Lisha Jeena; Esther Awuor; Jane Kahindi; Marianne Munene; Samson Kinyanjui; Sassy Molyneux; Vicki Marsh; Dorcas Kamuya
Journal:  Wellcome Open Res       Date:  2022-06-21

3.  Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource.

Authors:  Angela Wood; Rachel Denholm; Sam Hollings; Jennifer Cooper; Samantha Ip; Venexia Walker; Spiros Denaxas; Ashley Akbari; Amitava Banerjee; William Whiteley; Alvina Lai; Jonathan Sterne; Cathie Sudlow
Journal:  BMJ       Date:  2021-04-07

Review 4.  Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration.

Authors:  Feras M Ghazawi; Megan Lim; Jan P Dutz; Mark G Kirchhof
Journal:  Int J Dermatol       Date:  2020-07-03       Impact factor: 2.736

5.  Evidence is Lacking for the NHS England Interim Guidance for Managing Metastatic Non-small Cell Lung Cancer in the COVID-19 Pandemic.

Authors:  M Choudhury; S Nageshwaran; D Muthukumar
Journal:  Clin Oncol (R Coll Radiol)       Date:  2020-07-08       Impact factor: 4.126

6.  Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis.

Authors:  K Allen-Philbey; A Stennett; T Begum; A C Johnson; R Dobson; G Giovannoni; S Gnanapavan; M Marta; I Smets; B P Turner; D Baker; J Mathews; K Schmierer
Journal:  Mult Scler Relat Disord       Date:  2021-05-18       Impact factor: 4.808

Review 7.  A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come?

Authors:  Baila Shakaib; Tanzeel Zohra; Aamer Ikram; Muhammad Bin Shakaib; Amna Ali; Adnan Bashir; Muhammad Salman; Mumtaz Ali Khan; Jamil Ansari
Journal:  Virol J       Date:  2021-06-07       Impact factor: 4.099

Review 8.  Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2.

Authors:  Nikola Hudakova; Simona Hricikova; Amod Kulkarni; Mangesh Bhide; Eva Kontsekova; Dasa Cizkova
Journal:  Pathogens       Date:  2021-05-21

9.  Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial.

Authors:  Lotfollah Davoodi; Seyed Mohammad Abedi; Ebrahim Salehifar; Reza Alizadeh-Navaei; Hamed Rouhanizadeh; Ghasemali Khorasani; Seyed Jalal Hosseinimehr
Journal:  Int J Clin Pract       Date:  2020-07-17       Impact factor: 3.149

10.  Prospective data linkage to facilitate COVID-19 trials - A call to action.

Authors:  P A Paprica; M R Sydes; K M McGrail; A D Morris; M J Schull; R Walker
Journal:  Int J Popul Data Sci       Date:  2020-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.